Rutgers University
Cancer Immunotherapy, Cell Therapy (Assistant/Associate Professor)
Rutgers University, Trenton, New Jersey, United States,
Cancer Immunotherapy, Cell Therapy (Assistant/Associate Professor)
Rutgers Cancer Institute of New Jersey, a National Cancer Institute (NCI) Designated Comprehensive Cancer Center, seeks applications for a clinical research position at the Assistant/Associate Professor level to join the Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence. We seek candidates with
research emphasis on cancer immunotherapy and cell therapy , with a focus on first-in-human clinical trials conducted at Rutgers Cancer Institute of New Jersey using unique institutional resources such as on-site GMP manufacturing and state-of-the-art immune monitoring.
Clinical focus is open with additional opportunities in Phase I development.The successful candidate will join a team of researchers and clinicians of the newly established Cancer Immunology and Metabolism Center of Excellence, a $30 million initiative co-directed by Drs. Christian Hinrichs and Eileen White. The Program is built on our existing strengths in cancer metabolism and immunological research in partnership with Princeton University, and its clinical translation through our robust CAR-T therapy program with onsite GMP manufacturing and first-in-human clinical trials. The research program is based on an iterative bench to bedside strategy of investigator-initiated research in which laboratory discovery drives clinical trials, and clinical trials drive laboratory research. This is an exciting opportunity to join a developing world-class cancer immunology and immunotherapy program and a cellular therapy center of excellence. Attractive laboratory packages exist for qualified candidates.Rutgers Cancer Institute of New Jersey, the state’s only NCI-designated Comprehensive Cancer Center located in New Brunswick, NJ, and RWJBarnabas Health, the state’s largest health care delivery system, partner to deliver high-quality and sophisticated oncology care to patients close to home. This integrated cancer care model combines the strength of both entities, offering access to the most advanced diagnostic and treatment options for adult and pediatric cancer patients, including clinical trials, immunotherapy, proton therapy, precision medicine, CAR T-cell therapy and cardio-oncology. Unique opportunities exist for collaborations between clinical and research programs, including clinical trials research, cancer chemoprevention, clinical and basic pharmacology, and Phase 1 clinical trials.Qualifications:MD, DOHem/Onc 3-yr fellowship training or progress of completingBoard certified ABIM, Oncology certified/eligibleActive NJML or qualify for NJMLFor questions on this position or to learn more about our available positions, please contact the Rutgers Cancer Institute Faculty Recruitment Office at
cinjcareers@cinj.rutgers.edu .Applicants should submit a CV, a cover letter detailing how the candidate's work will contribute to the Rutgers Cancer Institute Mission, and list 3 references with contact information.
#J-18808-Ljbffr
Rutgers Cancer Institute of New Jersey, a National Cancer Institute (NCI) Designated Comprehensive Cancer Center, seeks applications for a clinical research position at the Assistant/Associate Professor level to join the Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence. We seek candidates with
research emphasis on cancer immunotherapy and cell therapy , with a focus on first-in-human clinical trials conducted at Rutgers Cancer Institute of New Jersey using unique institutional resources such as on-site GMP manufacturing and state-of-the-art immune monitoring.
Clinical focus is open with additional opportunities in Phase I development.The successful candidate will join a team of researchers and clinicians of the newly established Cancer Immunology and Metabolism Center of Excellence, a $30 million initiative co-directed by Drs. Christian Hinrichs and Eileen White. The Program is built on our existing strengths in cancer metabolism and immunological research in partnership with Princeton University, and its clinical translation through our robust CAR-T therapy program with onsite GMP manufacturing and first-in-human clinical trials. The research program is based on an iterative bench to bedside strategy of investigator-initiated research in which laboratory discovery drives clinical trials, and clinical trials drive laboratory research. This is an exciting opportunity to join a developing world-class cancer immunology and immunotherapy program and a cellular therapy center of excellence. Attractive laboratory packages exist for qualified candidates.Rutgers Cancer Institute of New Jersey, the state’s only NCI-designated Comprehensive Cancer Center located in New Brunswick, NJ, and RWJBarnabas Health, the state’s largest health care delivery system, partner to deliver high-quality and sophisticated oncology care to patients close to home. This integrated cancer care model combines the strength of both entities, offering access to the most advanced diagnostic and treatment options for adult and pediatric cancer patients, including clinical trials, immunotherapy, proton therapy, precision medicine, CAR T-cell therapy and cardio-oncology. Unique opportunities exist for collaborations between clinical and research programs, including clinical trials research, cancer chemoprevention, clinical and basic pharmacology, and Phase 1 clinical trials.Qualifications:MD, DOHem/Onc 3-yr fellowship training or progress of completingBoard certified ABIM, Oncology certified/eligibleActive NJML or qualify for NJMLFor questions on this position or to learn more about our available positions, please contact the Rutgers Cancer Institute Faculty Recruitment Office at
cinjcareers@cinj.rutgers.edu .Applicants should submit a CV, a cover letter detailing how the candidate's work will contribute to the Rutgers Cancer Institute Mission, and list 3 references with contact information.
#J-18808-Ljbffr